Русский
Assessment of the risk of developing cardiovascular diseases on the SCORE-2 and SCORE 2-OP scale in patients with arterial hypertension using software tools
DOI: https://dx.doi.org/10.18565/therapy.2022.3.67-71
Derevyanchenko M.V., Fedotov V.V., Shaposhnikova M.Yu., Kolodin S.V.
1) Volgograd State Medical University of the Ministry of Healthcare of Russia; 2) Volgograd State Technical University
The aim: conducting a screening assessment of cardiovascular risk (CVR) in patients with AH on the SCORE-2 and SCORE2-OP scales using digital software tools.
Material and methods. A team of authors created an Internet resource HeartCare, which allows you to automatically calculate the CVR according to the input data («Sex», «The fact of smoking», «Age», «SBP», « non-HDL cholesterol»). 80 people (38 women and 42 men) with AH aged from 45 to 70 years were included. The clinical status was assessed: complaints, anamnesis morbi and vitae, SBP and non-HDL cholesterol levels. The vascular age (VA) of patients was calculated – the program included the initial data of the subjects without taking into account risk factors (FR): smoking status, elevated levels of SBP, non-HDL cholesterol, after which a comparison was made of the «ideal» and actual CVR, which made it possible to calculate the difference between the chronological and VA patients.
Results. There were 14% smokers among the surveyed. Positive smoking status increased CVR up to 50%. The mean value of SBP was 157,6±14.2 mm Hg. Non-HDL cholesterol values repeated from 3,00 to 6,71 mmol/l. The average value was 4,5±1,0 mmol/l. The maximum value of the degree of risk of developing CVD in the study group was 41%, the minimum – 5%. The average value of the CVR was 21,6%. In the context of the group, only 5 people had moderate CV risk, 75 people had high CV risk. The average value of the qualitative indicator of CVR was 1,9±0,2, where 0 – «Low risk», 1 – «Moderate risk», 2 – «High risk». The VA of the sample is, on average, 13,2±2,8 years higher than the biological one. This indicates the identification of the contribution of indicators «The fact of smoking» and «Non-HDL cholesterol» on the CVR in the target group.
Conclusion. The SCORE-2 and SCORE2-OP software model can be used to estimate the rate of increase or decrease in CVR; to analyze of the effectiveness of prevention and treatment of AH in dynamics in individual patients. Automating the calculation of scale values and uploading them to an Internet resource allows them to be used not only by doctors, but also by patients themselves in order to control CVR at home.
Literature
1. Ярмонова М.В., Чайкина Н.Н., Ярмонов С.Н. О заболеваемости населения сердечно-сосудистыми заболеваниями и путях ее профилактики на региональном уровне. The Scientific Heritage. 2022; 82–2: 45–48. [Yarmonova M.V., Chaikina N.N., Yarmonov S.N. On the morbidity of the population with cardiovascular diseases and ways of its prevention at the regional level. The Scientific Heritage. 2022; 82–2: 45–48 (In Russ.)]. https://dx.doi.org/10.24412/9215-0365-2022-82-2-45-48. 2. Бойцов С.А., Погосова Н.В., Бубнова М.Г. с соавт. Кардиоваскулярная профилактика 2017. Российские национальные рекомендации. Российский кардиологический журнал. 2018; 6: 7–122. [Boytsov S.A., Pogosova N.V., Bubnova M.G. et al. Cardiovascular prevention 2017. Russian national recommendations. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2018; 6: 7–122 (In Russ.)]. https://dx.doi.org/10.15829/1560-4071-2018-6-7-122. 3. Atar D., Jukema J.W., Molemans B. et al. New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention? Atherosclerosis. 2021; 319: 51–61. https://dx.doi.org/10.1016/j.atherosclerosis.2020.12.013. 4. Шальнова С.А. Комментарии к разделу «Оценка сердечно-сосудистого риска» в европейских рекомендациях по профилактике сердечно-сосудистых заболеваний в клинической практике 2021 года. Кардиоваскулярная терапия и профилактика. 2022; 1: 67–71. [Shalnova S.A. Comments on the section «assessment of cardiovascular risk» in the European recommendations for the prevention of cardiovascular diseases in clinical practice 2021. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2022; 1: 67–71 (In Russ.)]. https://dx.doi.org/10.15829/1728-8800-2022-3171. 5. Жмуров Д.В., Парфентева М.А., Семенова Ю.В. Артериальная гипертензия. Colloquium-journal. 2020; 30–1: 48–56. [Zhmurov D.V., Parfentieva M.A., Semenova Yu.V. Arterial hypertension. Colloquium-journal. 2020; 30–1: 48–56 (In Russ.)]. https://dx.doi.org/10.24411/2520-6990-2020-12232. 6. Гаврилов Д.В., Гусев А.В., Никулина А.В. с соавт. Правильность оценки сердечно-сосудистого риска в повседневной клинической практике. Профилактическая медицина. 2021; 4: 69–75. [Gavrilov D.V., Gusev A.V., Nikulina A.V. et al. Correctness of cardiovascular risk assessment in everyday clinical practice. Profilakticheskaya meditsina = Preventive Medicine. 2021; 4: 69–75 (In Russ.)]. https://dx.doi.org/10.17116/profmed20212404169. 7. Чазова И.Е., Жернакова Ю.В. от имени экспертов. Клинические рекомендации. Диагностика и лечение артериальной гипертонии. Системные гипертензии. 2019; 1: 6–31. [Chazova I.E., Zhernakova Yu.V. on behalf of the experts. Clinical guidelines. Diagnosis and treatment of arterial hypertension. Sistemnyye gipertenzii = Systemic Hypertension. 2019; 1: 6–31 (In Russ.)]. https://dx.doi.org/10.26442/2075082X.2019.1.190179. 8. Турдиев М.Р., Исмаилов С.И., Камилова У.К. Оценка факторов риска и сердечно-сосудистого риска в профилактике сердечно-сосудистых заболеваний. Евразийский кардиологический журнал. 2019; S1: 72. [Turdiev M.R., Ismailov S.I., Kamilova U.K. Assessment of risk factors and cardiovascular risk in the prevention of cardiovascular diseases. Yevraziyskiy kardiologicheskiy zhurnal = Eurasian Journal of Cardiology. 2019; S1: 72 (In Russ.)]. 9. Cooney M.T., Selmer R., Lindman A. et al. SCORE and CONOR investigators. Cardiovascular risk estimation in older persons: SCORE O.P. Eur J Prev Cardiol. 2016; 23(10): 1093–103. https://dx.doi.org/10.1177/2047487315588390. 10. Piccininni M., Rohmann J.L., Huscher D. et al. Correction: Performance of risk prediction scores for cardiovascular mortality in older persons: External validation of the SCORE OP and appraisal. PLoS One. 2020; 15(5): e0233051. https://dx.doi.org/10.1371/journal.pone.0233051.
About the Autors
Maria V. Derevyanchenko, Dr. med. habil., professor of the Department of internal diseases, Volgograd State Medical University of the Ministry of Healthcare of Russia. Address: 400005, Volgograd, 47 Sovetskaya Str. E-mail: derevjanchenko@gmail.com
Vladislav V. Fedotov, student at Volgograd State Medical University of the Ministry of Healthcare of Russia. Address: 400131, Volgograd, 1 Pavshikh Bortsov Sq. E-mail: yetiv0@mail.ru
Maya Yu. Shaposhnikova, student at Volgograd State Medical University of the Ministry of Healthcare of Russia. Address: 400131, Volgograd, 1 Pavshikh Bortsov Sq. E-mail: mayya.shaposhnikova@bk.ru
Semyon V. Kolodin, bachelor, Volgograd State Polytechnic University. Address: 400005, Volgograd, 28 Lenina Avenue. E-mail: noizypumpkin@gmail.com
Similar Articles
